Article thumbnail

EGF regulates survivin stability through the Raf-1/ERK pathway in insulin-secreting pancreatic β-cells

By Haijuan Wang, Katarina Gambosova, Zachary A Cooper, Michael P Holloway, Andrea Kassai, Denisse Izquierdo, Kelly Cleveland, Charlotte M Boney and Rachel A Altura
Topics: Research Article
Publisher: BioMed Central
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (2004). Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature
  2. (2006). AF: Molecular control of cell cycle progression in the pancreatic beta-cell. Endocr Rev
  3. (2008). al: Postnatal expansion of the pancreatic {beta}-cell mass is dependent on survivin. Diabetes
  4. (2008). al: Postnatal expansion of the pancreatic beta-cell mass is dependent on survivin. Diabetes
  5. (1995). al: Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. Science
  6. (1998). Altieri DC: Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting.
  7. (2006). Altieri DC: Inhibition of apoptosis by survivin improves transplantation of pancreatic islets for treatment of diabetes in mice. EMBO Rep
  8. (2000). Altieri DC: Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin. Proc Natl Acad Sci USA
  9. (2002). Altieri DC: Survivin exists in immunochemically distinct subcellular pools and is involved in spindle microtubule function.
  10. (2004). Autocrine regulation of single pancreatic beta-cell survival. Diabetes
  11. (2004). Bhushan A: Beta cell replication is the primary mechanism for maintaining postnatal beta cell mass.
  12. (2008). cancer networks and pathway-directed drug discovery. Nat Rev Cancer
  13. (2005). Chromosome alignment and segregation regulated by ubiquitination of survivin. Science
  14. (2006). CozarCastellano I, Garcia-Ocana A: Growth factors and beta cell replication.
  15. (1995). Derynck R: Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor. Nature
  16. (2009). Dikic I: Functional roles of ubiquitin-like domain (ULD) and ubiquitin-binding domain (UBD) containing proteins. Chem Rev
  17. (2004). Earnshaw WC: Aurora-B phosphorylation in vitro identifies a residue of survivin that is essential for its localization and binding to inner centromere protein (INCENP) in vivo.
  18. (2005). EGFR enhances Survivin expression through the phosphoinositide 3 (PI-3) kinase signaling pathway. Exp Mol Pathol
  19. (2006). et al: Insulin protects islets from apoptosis via Pdx1 and specific changes in the human islet proteome. Proc Natl Acad Sci USA
  20. (2004). Hynes NE: ErbB receptors: directing key signaling networks throughout life. Annu Rev Pharmacol Toxicol
  21. (2008). Inhibition of Raf-1 alters multiple downstream pathways to induce pancreatic beta-cell apoptosis.
  22. (2008). Insulin stimulates primary beta-cell proliferation via Raf-1 kinase. Endocrinology
  23. (2008). Insulin-like growth factor-I receptor signaling pathway induces resistance to the apoptotic activities of SCH66336 (lonafarnib) through Akt/mammalian target of rapamycinmediated increases in survivin expression. Clin Cancer Res
  24. (2000). KH: Survivin and the inner centromere protein INCENP show similar cellcycle localization and gene knockout phenotype. Curr Biol
  25. (2000). Life and death of the pancreatic beta cells. Trends Endocrinol Metab
  26. (2000). NR: The ubiquitinproteasome pathway regulates survivin degradation in a cell cycledependent manner.
  27. (2006). Otonkoski T: Downregulation of EGF receptor signaling in pancreatic islets causes diabetes due to impaired postnatal beta-cell growth. Diabetes
  28. (2000). Otonkoski T: Impaired migration and delayed differentiation of pancreatic islet cells in mice lacking EGF-receptors. Development
  29. (2008). PC: Beta-cell replication is the primary mechanism subserving the postnatal expansion of beta-cell mass in humans. Diabetes
  30. (2009). Perinatal survivin is essential for the establishment of pancreatic beta cell mass in mice. Diabetologia
  31. (2000). Perspective: Postnatal pancreatic beta cell growth. Endocrinology
  32. (1998). Proteasome inhibitors: valuable new tools for cell biologists. Trends Cell Biol
  33. (2004). Raf kinase inhibitory protein inhibits beta-cell proliferation. Surgery
  34. (1998). Rapid activation and nuclear translocation of mitogen-activated protein kinases in response to physiological concentration of glucose in the MIN6 pancreatic beta cell line.
  35. (1998). Reed JC: IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res
  36. (2006). RH: The case for Survivin as mitotic regulator. Curr Opin Cell Biol
  37. (2000). RL: Human survivin is a kinetochore-associated passenger protein.
  38. (2005). Rooman I: Regulation of pancreatic beta-cell mass. Physiol Rev
  39. (2001). Sliwkowski MX: Untangling the ErbB signalling network. Nat Rev Mol Cell Biol
  40. (2002). Stukenberg PT: Aurora B kinase exists in a complex with survivin and INCENP and its kinase activity is stimulated by survivin binding and phosphorylation. Mol Biol Cell
  41. (2003). Survivin, versatile modulation of cell division and apoptosis in cancer. Oncogene
  42. (2006). The case for survivin as a regulator of microtubule dynamics and cell-death decisions. Curr Opin Cell Biol
  43. (2009). The multiple layers of ubiquitindependent cell cycle control. Chem Rev
  44. (2000). Tokuhisa T: Cell cycle-dependent regulation of TIAP/m-survivin expression. Biochim Biophys Acta
  45. (1995). Wagner EF: Strain-dependent epithelial defects in mice lacking the EGF receptor. Science
  46. (2006). Yarden Y: EGF-ERBB signalling: towards the systems level. Nat Rev Mol Cell Biol